Somashekhar Sampige Prasanna, Deo Suryanarayana, Thammineedi Subramanyeshwar Rao, Chaturvedi Harit, Mandakukutur Subramanya Ganesh, Joshi Rama, Kothari Jagdish, Srinivasan Ayyappan, Rohit Kumar C, Ray Mukurdipi, Prajapati Bharat, Guddahatty Nanjappa Hemanth, Ramalingam Rajagopalan, Fernandes Aaron, Ashwin Kyatsandra Rajagopal
Aster International Institute of Oncology , Aster hospital , Bengaluru, India.
Department of Surgical Oncology, All India Institute of Medical Sciences, New Delhi, India.
Pleura Peritoneum. 2023 May 22;8(2):91-99. doi: 10.1515/pp-2022-0198. eCollection 2023 Jun.
The Enhanced recovery after surgery (ERAS) program is designed to achieve faster recovery by maintaining pre-operative organ function and reducing stress response following surgery. A two part ERAS guidelines specific for Cytoreductive surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) was recently published with intent of extending the benefit to patients with peritoneal surface malignancies. This survey was performed to examine clinicians' knowledge, practice and obstacles about ERAS implementation in patients undergoing CRS and HIPEC.
Requests to participate in survey of ERAS practices were sent to 238 members of Indian Society of Peritoneal Surface malignancies (ISPSM) via email. They were requested to answer a 37-item questionnaire on elements of preoperative (n=7), intraoperative (n=10) and postoperative (n=11) practices. It also queried demographic information and individual attitudes to ERAS.
Data from 164 respondents were analysed. 27.4 % were aware of the formal ERAS protocol for CRS and HIPEC. 88.4 % of respondents reported implementing ERAS practices for CRS and HIPEC either, completely (20.7 %) or partially (67.7 %). The adherence to the protocol among the respondents were as follows: pre operative (55.5-97.6 %), intra operative (32.6-84.8 %) and post operative (25.6-89 %). While most respondents considered implementation of ERAS for CRS and HIPEC in the present format, 34.1 % felt certain aspects of perioperative practice have potential for improvement. The main barriers to implementation were difficulty in adhering to all elements (65.2 %), insufficient evidence to apply in clinical practice (32.4 %), safety concerns (50.6 %) and administrative issues (47.6 %).
Majority agreed the implementation of ERAS guidelines is beneficial but are followed by HIPEC centres partially. Efforts are required to overcome barriers like improving certain aspects of perioperative practice to increase the adherence, confirming the benefit and safety of protocol with level I evidence and solving administrative issues by setting up dedicated multi-disciplinary ERAS teams.
术后加速康复(ERAS)计划旨在通过维持术前器官功能和减轻术后应激反应来实现更快的康复。最近发布了一份针对减瘤手术(CRS)和热灌注化疗(HIPEC)的两部分ERAS指南,旨在将其益处扩展到腹膜表面恶性肿瘤患者。本次调查旨在了解临床医生对接受CRS和HIPEC手术患者实施ERAS的知识、实践情况及障碍。
通过电子邮件向印度腹膜表面恶性肿瘤协会(ISPSM)的238名成员发送参与ERAS实践调查的邀请。要求他们回答一份关于术前(n = 7项)、术中(n = 10项)和术后(n = 11项)实践要素的37项问卷。问卷还询问了人口统计学信息以及个人对ERAS的态度。
分析了164名受访者的数据。27.4%的人知晓针对CRS和HIPEC的正式ERAS方案。88.4%的受访者报告称对CRS和HIPEC实施了ERAS实践,其中完全实施的占20.7%,部分实施的占67.7%。受访者对方案的依从性如下:术前(55.5 - 97.6%)、术中(32.6 - 84.8%)和术后(25.6 - 89%)。虽然大多数受访者认可以当前形式对CRS和HIPEC实施ERAS,但34.1%的人认为围手术期实践的某些方面仍有改进空间。实施的主要障碍包括难以遵守所有要素(65.2%)、临床实践中应用的证据不足(32.4%)、安全担忧(50.6%)和管理问题(47.6%)。
大多数人认为实施ERAS指南是有益的,但HIPEC中心只是部分遵循。需要努力克服障碍,如改进围手术期实践的某些方面以提高依从性,以一级证据证实方案的益处和安全性,以及通过设立专门的多学科ERAS团队解决管理问题。